ArticlePloS one2021

Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer.

Katsuhiro Yoshikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.